Point-of-care haematological monitoring during treatment with clozapine

Point-of-care haematological monitoring during treatment with clozapine

Patients treated with clozapine are required to have regular venous blood samples taken to measure white blood cell (WBC) and neutrophil counts to reduce the risk of agranulocytosis. The need for regular venous blood sampling can deter patients and clinicians from treatment with clozapine. Finger pr...

Full description

Bibliographic Details
Main Authors: Atkins Matthew, McGuire Philip, Balgobin Bhirundra, Williams Sophie, Ceesay Fatou, Desouza Neville, Patel Pravinkumar, Taylor David
Format: Article
Language:English
Published: De Gruyter 2022-06-01
Series:Journal of Laboratory Medicine
Subjects:
capillary blood sample
clozapine
point of care
Online Access:https://doi.org/10.1515/labmed-2021-0181

Internet

https://doi.org/10.1515/labmed-2021-0181

Similar Items